Clinical Trials in New York

Showing 3001-3020 of 10,830 trials

XEN1101 for Major Depressive Disorder

NCT04827901

This project is designed to examine the neuronal KCNQ2/3 potassium (K+) channel subtype as a novel treatment target for mood disorders through the administration of the KCNQ-selective channel opener XEN1101 (Xenon Pharmaceuticals).

Major Depressive Disorder

James Murrough44 participantsStarted Oct 2021

New York, New York, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

The DETOUR 2 Clinical Trial

NCT03119233

Prospective, single-arm, multi-center, international clinical investigation to evaluate the safety and effectiveness of the PQ Bypass System to access, deliver guidewires, and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.

Peripheral Arterial Disease

Endologix202 participantsStarted Dec 2017

Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States +31 more locations

XEN1101 for Major Depressive Disorder

The DETOUR 2 Clinical Trial

Find Trials by Condition in New York

Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

Exoskeletal Support in Stroke

Lower Tourniquet Pressure Study

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

MOTIV BTK Randomized Controlled Trial

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)